Quantum BioPharma News - September 14, 2026

🟢 Quantum BioPharma is trading 10.62% up today after renewed attention to FDA clearance for its Phase 2 Lucid-MS trial

Quantum BioPharma is trading 10.62% up at $3.54 after renewed attention to FDA clearance for its Phase 2 Lucid-MS trial in multiple sclerosis. - A September...

🟢 Quantum BioPharma is trading 6.25% up today after FDA clearance for Phase 2 Lucid-MS trial

Quantum BioPharma is trading 6.25% up at $3.40 after renewed attention to its September 11 FDA-clearance announcement for a Phase 2 Lucid-MS trial in multiple...